Komori
Changes in Officers4559ZERIA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Concerning the Nomination of Director Candidates

The Company has decided on 7 director candidates for the annual general meeting of shareholders scheduled for 26 June 2026. 6 are candidates for reappointment, and 児林 Satomi (児林 聡美) has newly been selected as a candidate for outside director.

Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 8 May 2026

Incoming appointee

1 item
Scheduled Appointment Date26 June 2026 (subject to approval at the 72nd Annual General Meeting of Shareholders)
児林 Satomi (児林 聡美)
Previous positionRepresentative Member of 合同会社ヘルスM&S (current), Director of 一般社団法人日本職域栄養協会 (current)
New positionOutside directors
Directors after the change7Number
Shareholders’ meeting approvalRequired. A proposal for the selection of the director candidates will be submitted to the 72nd Annual General Meeting of Shareholders, scheduled for 26 June 2026.
Who is moving to which position
ItemDetails
Resolution date8 May 2026
Scheduled Appointment Date26 June 2026 (subject to approval at the 72nd Annual General Meeting of Shareholders)
Name of appointee児林 Satomi (児林 聡美)
Appointee's new positionOutside directors
Appointee's previous positionRepresentative Member of 合同会社ヘルスM&S (current), Director of 一般社団法人日本職域栄養協会 (current)
Number of directors after the change7 (including 4 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. A proposal for the selection of the director candidates will be submitted to the 72nd Annual General Meeting of Shareholders, scheduled for 26 June 2026.
Items this document does not state (14)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company does not appear to have disclosed specific reasons for the selection or the personnel changes.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Nomination of Director Candidates | ZERIA PHARMACEUTICAL CO.,LTD. (4559) timely disclosure | Komori